KRAS and BRAF Mutation Detection: Is Immunohistochemistry a Possible Alternative to Molecular Biology in Colorectal Cancer?

Figure 2

Immunohistochemical analysis of KRAS mutated colorectal cancer with positive staining, ×200 HPF.